Antidepressant lawsuits against GSK, Pfizer back on
Pharma Compliance Alert, March 18, 2009
Pharmaceutical companies are already seeing the fallout from the Supreme Court’s decision permitting patients to sue under state product liability laws.
The Supreme Court ruled March 4 that FDA approval does not shield pharmaceutical manufacturers from patient lawsuits. The following week the Supreme Court ordered U.S. Court of Appeals for the Third Circuit in Philadelphia to reexamine lawsuits against GlaxoSmithKline (GSK) and Pfizer, according to the Associated Press.
GSK and Pfizer failed to warn consumers that their antidepressants Paxil and Zoloft could increase the risk of suicide in adults, according to the lawsuits. The Appeals Court initially ruled that the FDA concluded suicide warnings for adults would be misleading.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
